Todd E. Simpson, Chief Financial Officer at SEATTLE GENETICS INC /WA (SGEN), sold 28,054 shares at $155.69 ($4.4M) on 2020-08-31, disclosed to the SEC on 2020-09-02.
Seasonal sale ($4.4M) by Chief Financial Officer — this insider has traded SGEN in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.69 | 2,065 | $322K | 7.4% |
| 2 | $155.69 | 2,122 | $330K | 7.6% |
| 3 | $155.69 | 2,122 | $330K | 7.6% |
| 4 | $155.69 | 2,065 | $321K | 7.4% |
| 5 | $155.25 | 4,452 | $691K | 15.8% |
| 6 | $155.74 | 5,480 |
| $853K |
| 19.5% |
| 7 | $155.74 | 5,480 | $853K | 19.5% |
| 8 | $156.87 | 1,640 | $257K | 5.9% |
| 9 | $156.87 | 1,640 | $257K | 5.9% |
| 10 | $157.82 | 50 | $8K | 0.2% |
| 11 | $159.33 | 469 | $75K | 1.7% |
| 12 | $159.33 | 469 | $75K | 1.7% |
| Total | $155.90 avg | 28,054 | $4.4M | 100% |
| Filing → |
| SGEN | SELL | 2023-08-30 | $100K | — | Filing → |
| SGEN | SELL | 2023-04-12 | $22.6M | — | Filing → |
| SGEN | SELL | 2023-04-07 | $100K | — | Filing → |